IBS & irritable bowel Board decisions

The Board granted earlier effective dates for some conditions and denied an earlier effective date for lumbosacral strain, while remanding service connection claims for left and right wrist disorders.

The Board granted an initial 10 percent rating for irritable bowel syndrome from August 10, 2022.

The Board granted an initial 30 percent disability rating for the service-connected irritable bowel syndrome (IBS) for the entire period on appeal.

The Board denied the veteran's claims for increased ratings and service connection, as no evidence supported higher ratings or a grant of service connection.

The Board granted service connection for right arm radiculopathy and an initial 30 percent evaluation for irritable bowel syndrome (IBS), while remanding the remaining claims.

The Board granted service connection for a right hip disorder and irritable bowel syndrome (IBS) but denied service connection for right foot, left foot, and gastroesophageal reflux disease (GERD) disorders. The claim for an acquired psychiatric disorder was remanded.

The Board denied service connection for irritable bowel syndrome, bilateral plantar fasciitis, and a temporomandibular disorder, including TMJ, as the evidence did not support current diagnoses or functional impairment during the pendency of the claims.

The appeal for a higher disability rating for gall bladder removal with diarrhea (claimed as irritable bowel syndrome) was dismissed due to the Veteran's withdrawal of the appeal.

The Board denied an evaluation higher than 30 percent for the service-connected irritable bowel syndrome with functional abdominal pain syndrome and remanded several other issues related to service connection.

The Board denied service connection for irritable bowel syndrome, gastroesophageal reflux disease, and a compensable rating for 5th digit strain of the left hand due to lack of evidence linking these conditions to the Veteran's military service.

The Board remands the claims for an initial compensable rating and earlier effective date for irritable bowel syndrome due to a need for a new VA examination.

The Board granted an earlier effective date of July 24, 2021, for the grant of service connection for irritable bowel syndrome (IBS).

The Board denied the veteran's claims for an initial compensable evaluation for sinusitis and irritable bowel syndrome (IBS), as well as a disability rating in excess of 10 percent for IBS prior to May 19, 2024.

The Board remands the claims for service connection for bilateral hand tremors, respiratory insufficiency-dyspnea, chronic fatigue syndrome (CFS), irritable bowel syndrome (IBS), and hypertension to obtain further medical opinions.

The Board denied service connection for irritable bowel syndrome (IBS) as the evidence did not support a finding that it began during active service or is related to an in-service injury.

The Board granted service connection for migraine headaches as secondary to the Veteran's service-connected PTSD and remanded several other claims for further development.

The Board granted service connection for lumbosacral strain, left and right lower extremity radiculopathy, irritable bowel syndrome (IBS), and a compensable disability rating for tension/common headaches.

The Board granted service connection for chronic diarrhea (also claimed as irritable bowel syndrome) and remanded the claims for pleuritis, sinusitis, left wrist tendinopathy (tendinitis), and bilateral plantar fasciitis.

The Board denied the veteran's claim for a disability evaluation in excess of 10 percent for non-allergic rhinitis, as there was no evidence of nasal polyps. The claims for IBS and fibromyalgia were remanded for further examination.

The Board granted an effective date of August 10, 2022, but no earlier for entitlement to service connection for chronic sinusitis and allergic rhinitis. The Board denied an earlier effective date for irritable bowel syndrome and DEA benefits.